The UK’s Medicines and Healthcare products Regulatory Agency and its Swiss counterpart, Swissmedic, have entered into a collaborative agreement that will allow the agencies to share information and better fulfill their public safety roles.

The agreement — which was signed during the 11th Summit of the Heads of Medicines Regulatory Agencies by MHRA’s Chief Executive Ian Hudson and Swissmedic’s Executive Director Jürg H. Schnetzer — is intended to provide the agencies with a shared approach to complex challenges.

It includes provisions for the agencies to promote each other’s regulatory frameworks, requirements and processes as well. “We operate in a global environment and agreements such as these serve to further strengthen our ability to promote good practices,” Hudson said.